Dendritic Cell Directed Stem Cell Differentiation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating lineage-specific precursor/progenitor cells are limited in their ability to effectively direct the differentiation and expansion of tissue-derived cells for therapeutic and diagnostic applications, particularly in enhancing immune responses and tissue regeneration.
Innovation Solution
An in vitro method involving the co-culture of dendritic cells, activated by specific cytokines, with stem/progenitor cells to induce differentiation and expansion, resulting in a lineage-specific precursor/progenitor cell population with enhanced cytotoxic activity and regenerative capabilities.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional methods are used to generate lineage-specific precursor/progenitor cells, then the process is simpler, but the ability to effectively direct differentiation and expansion is limited
Solution Approach 1:
The patent introduces dendritic cells as intermediary directing cells that mediate between the culture system and stem/progenitor cells. These DCs secrete cytokines and chemokines that specifically guide the differentiation of stem cells into desired lineage-specific precursor cells, thereby improving differentiation directionality while managing system complexity through a biologically-mediated approach
2Manufacturing precision
If dendritic cells are used to direct stem cell differentiation, then differentiation precision is improved, but the culture system becomes more complex
Solution Approach 1:
The patent employs dendritic cells that can be activated in different stages (immature, semi-mature, mature forms) with distinct cytokine secretion profiles. By controlling the activation state and timing of DCs, the system achieves precise differentiation control through dynamic parameter changes in cytokine concentrations and cell maturity levels, rather than requiring complex static culture conditions
3Productivity
If stem/progenitor cells are expanded without directing cells, then expansion speed is faster, but lineage specificity is reduced
Solution Approach 1:
The patent implements a staged approach where dendritic cells are activated in advance to establish a supportive microenvironment before introducing stem/progenitor cells. The pre-activated DCs secreted cytokines that prime the culture system for efficient expansion, allowing subsequent rapid proliferation while maintaining lineage specificity through the pre-established directional signals
Data Source
Figure 1A~1B
Figure 2A~2B
Figure 3A~3B
AI summary
A method is provided, including obtaining a population of antigen-presenting cells, enriching a population of stem/progenitor cells within a larger population of cells, activating the population of antigen-presenting cells and, following the activating, inducing at least one process selected from the group consisting of: differentiation, expansion, activation, secretion of a molecule, and expression of a marker, by exposing the enriched stem/progenitor cell population to the population of antigen-presenting cells. Other applications are also described.